SALVUS COMPLAINT TO 10+ PHARMACEUTICAL REGULATORY AGENCIES
Achieve more with less
Crypta streamlines literature screening by offering an intelligent and efficient method for handling literature monitoring, identifying pertinent cases, and submitting them to your safety database. Enhance compliance and save valuable time with Crypta
Automated Literature Review Process
Our process automation minimizes manual effort and reduces human errors, resulting in significant time and cost savings.
Strategic Focus
Our faster literature screening capabilities allow safety teams to allocate more time and attention to strategic goals while effectively managing an increasing volume of items to process.
Relevant Extract
Our automated screening efficiently extracts relevance, ensuring that only pertinent cases are submitted to your safety database while effectively filtering out irrelevant information.
Automated ICSR Detection
Our auto detection of ICSR provides up to 80% efficiency gains.
Auto Generation of E2B R2 and R3 XML
Our auto detection of ICSR provides up to 80% efficiency gains.
INTEGRATED PLATFORM
A platform for guaranteed compliance
With ICH, EMA, FDA, EU GMP Annex 11, US FDA 21 CFR part 11, and EMA’s Good Pharmacovigilance Practice (GVP) guidelines, Crypta is compliant with many regulations and directives from around the world.
We love our customers. Happily, the feeling is mutual.
Salvus has been a game-changer for our pharmacovigilance operations. Its GxP-ready and CFR-11 compliant features have ensured our compliance with industry regulations. The automated intake and E2B R2/R3 XML Import and Export support have significantly streamlined our data handling processes, saving time and improving efficiency.
Stanley Joel
​
Senior VP, Emzor Pharmaceuticals
Emzor Pharmaceutics
See why business teams choose Crypta
Experience the everyday excellence of a unified, AI-powered solution to all your business needs
